Lippman, Steve; Rosan, Daniel E.; Seitchik, Adam - In: Corporate Governance: An International Review 15 (2007) 3, pp. 455-466
Changes in prescription drug prices have broad ripple effects across the diverse portfolios that most institutional investors hold. Lower prices cut into pharmaceutical company profits, but improve the overall productivity and profitability of other investable sectors of the economy. This paper...